About Matter Bio

Matter Bio is a longevity holding company focused on preserving genome integrity by addressing mutations, structural variations, and epigenetic drift that accumulate with age. The company employs a team of scientists to develop targeted interventions that counteract genomic information loss, aiming to slow and potentially reverse key drivers of aging.

```xml <problem> Aging is characterized by the accumulation of damage to the genome, including mutations, structural variations, and epigenetic drift. This genomic instability leads to cellular dysfunction and age-related diseases. Current approaches to address aging often lack direct mechanisms for repairing or removing cells with corrupted DNA. </problem> <solution> Matter Bio is developing targeted interventions to protect cells from genomic damage and eliminate cells with corrupted DNA. The company focuses on enhancing cellular DNA damage repair mechanisms and removing cancerous cells to prevent and treat age-related diseases. By addressing the root causes of genomic instability, Matter Bio aims to slow down and potentially reverse key drivers of aging, ultimately extending lifespan. </solution> <features> - Enhances cellular DNA damage repair mechanisms to maintain genome integrity. - Develops methods for removing cells with corrupted DNA, including cancerous cells. - Focuses on addressing mutations, structural variations, and epigenetic drift. - Aims to prevent and treat a wide array of age-related diseases. </features> <target_audience> The primary target audience includes individuals and organizations interested in longevity, genetics, computational biology, and cancer research, as well as those seeking to prevent and treat age-related diseases. </target_audience> ```

What does Matter Bio do?

Where is Matter Bio located?

Matter Bio is based in East New York, United States.

When was Matter Bio founded?

Matter Bio was founded in 2022.

How much funding has Matter Bio raised?

Matter Bio has raised 7000000.

Who founded Matter Bio?

Matter Bio was founded by Christopher Bradley.

Christopher Bradley - CEO

Location

East New York, United States

Founded

2022

Funding

7000000

Employees

7 employees

Looking for specific startups?

Try our free semantic startup search

Matter Bio

Score: 78/100

AI-Generated Company Overview (experimental) – could contain errors

Executive Summary

matterbio.com 300+

Founded 2022 – East New York, United States

Funding

Estimated Funding

$7M+

Team (5+)

Christopher Bradley

CEO

Company Description

Problem

Aging is characterized by the accumulation of damage to the genome, including mutations, structural variations, and epigenetic drift. This genomic instability leads to cellular dysfunction and age-related diseases. Current approaches to address aging often lack direct mechanisms for repairing or removing cells with corrupted DNA.

Solution

Matter Bio is developing targeted interventions to protect cells from genomic damage and eliminate cells with corrupted DNA. The company focuses on enhancing cellular DNA damage repair mechanisms and removing cancerous cells to prevent and treat age-related diseases. By addressing the root causes of genomic instability, Matter Bio aims to slow down and potentially reverse key drivers of aging, ultimately extending lifespan.

Features

Enhances cellular DNA damage repair mechanisms to maintain genome integrity.

Develops methods for removing cells with corrupted DNA, including cancerous cells.

Focuses on addressing mutations, structural variations, and epigenetic drift.

Aims to prevent and treat a wide array of age-related diseases.

Target Audience

The primary target audience includes individuals and organizations interested in longevity, genetics, computational biology, and cancer research, as well as those seeking to prevent and treat age-related diseases.